Spot Trading’s Jazz Pharmaceuticals JAZZ Stock Holding History

Spot Trading’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$309K	Buy	+2,113	New	+$320K	0.01%	1963
2017 Q1	–	Sell	-679	Closed	-$74K	–	3126
2016 Q4	$74K	Buy	+679	New	+$75.6K	﹤0.01%	2305
2016 Q1	–	Sell	-4,872	Closed	-$685K	–	3702
2015 Q4	$685K	Sell	4,872 -400	-8%	-$55.4K	0.01%	1704
2015 Q3	$700K	Buy	+5,272	New	+$908K	0.01%	1833
2015 Q1	–	Sell	-196	Closed	-$32K	–	4104
2014 Q4	$32K	Sell	196 -1,133	-85%	-$188K	﹤0.01%	3521
2014 Q3	$213K	Sell	1,329 -300	-18%	-$46.1K	﹤0.01%	3152
2014 Q2	$239K	Sell	1,629 -778	-32%	-$108K	﹤0.01%	3216
2014 Q1	$334K	Buy	+2,407	New	+$362K	﹤0.01%	2834
2013 Q3	–	Sell	-4,836	Closed	-$390K	–	4248
2013 Q2	$332K	Buy	+4,836	New	+$296K	﹤0.01%	2714

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

SIG

Senator Investment Group New York $2.74B AUM 55.95% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Spot Trading's JAZZ Position: Q3 2017 in Review

Spot Trading opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2017: 2,113 shares worth $309K. The stake represents 0.01% of the portfolio and ranks #1963 among its holdings. This is a return to the name: Spot Trading previously reported a position in JAZZ as recently as Q4 2016.

Spot Trading first reported a position in JAZZ in Q2 2013 and has held it in 9 quarters since. The position peaked at $700K in Q3 2015. 303 funds tracked by Wall St. Rank hold JAZZ as of Q3 2017.

Spot Trading held 2,113 shares of Jazz Pharmaceuticals worth $309K as of Q3 2017.
Jazz Pharmaceuticals was a new Spot Trading position in Q3 2017.
Jazz Pharmaceuticals made up 0.01% of Spot Trading's portfolio in Q3 2017, its #1963 holding.
Spot Trading first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 9 quarters since.
Spot Trading's Jazz Pharmaceuticals position peaked at $700K in Q3 2015.
303 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.